Although CDHR1 has undergone extensive scrutiny within the context of retinal dystrophy, where mutations in CDHR1 hold potential therapeutic promise, and subtype alleles associated with CDHR1-linked retinitis pigmentosa variants have been identified (Malechka et al. 2022; Stingl et al. 2017), its exploration within the realm of TBI remains limited. Here, CDHR1 is linked to Retinal dystrophy.